MetaCap

Veradermics Statistics

NYSE: MANEHealth CareBiotechnology: Pharmaceutical PreparationsUSD

119.52-4.87 (-3.92%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Veradermics by the numbers

Veradermics has a market capitalization of $5.04 billion based on 42.20M shares outstanding. With trailing EPS of $-3.89, Veradermics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 4.2% below its 50-day average and 22.7% above its 200-day average.

Average daily trading volume is 738.22K shares, or about $88.2 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

MANE valuation vs. peer median

MANE compared with the median of 8 peer companies
MetricMANEPeer medianDifference
Market cap$5.04B$4.77B+6%
Avg. volume738.22K1.44M-49%

Peer median across 8 companies: BLTE, LQDA, ERAS, DNTH, PTCT, COGT, GRFS, TVTX.

Valuation

Price and trading

Previous close
124.39
Open
121.98
Day range
118.99 – 123.70
52-week range
32.00 – 156.63
Beta
—
Volume
374.92K

Dividends and events

Annual dividend
None
Next earnings date
Nov 10, 2026

Additional statistics

Market Cap
5.04B
Forward Pe
-46.31
Eps
-3.89
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
156.63
Week52 Low
32.00
Avg Volume
738.22K
Shares Outstanding
42.20M
Ma50
124.70
Ma200
97.38
Earnings Date
Nov 10, 2026
Pct From52w High
-23.69%
Pct From52w Low
273.50%

Related